Cargando…

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study

A recently published ERS core outcome set recommends that all trials of COPD exacerbation management should assess the treatment success (or “cure” of the exacerbation), defined as a dichotomous measure of the overall outcome of an exacerbation. This methodological systematic review describes and co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathioudakis, Alexander G., Ananth, Sachin, Bradbury, Thomas, Csoma, Balazs, Sivapalan, Pradeesh, Stovold, Elizabeth, Fernandez-Romero, Gustavo, Lazar, Zsofia, Criner, Gerard J., Jenkins, Christine, Papi, Alberto, Jensen, Jens-Ulrik, Vestbo, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698292/ https://www.ncbi.nlm.nih.gov/pubmed/34944653 http://dx.doi.org/10.3390/biomedicines9121837

Ejemplares similares

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
por: Mathioudakis, Alexander G., et al.
Publicado: (2020)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses
por: Csoma, Balázs, et al.
Publicado: (2021)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023)

Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
por: Kamstrup, Peter, et al.
Publicado: (2022)

Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Prevention of COPD exacerbations: medications and other controversies
por: Vestbo, Jørgen, et al.
Publicado: (2015)

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Automated oxygen control with O2matic(®) during admission with exacerbation of COPD
por: Hansen, Ejvind Frausing, et al.
Publicado: (2018)

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2023)

Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
por: Bagge, Kristian, et al.
Publicado: (2021)

Hypercapnia in COPD: Causes, Consequences, and Therapy
por: Csoma, Balázs, et al.
Publicado: (2022)

Sedating antihistamine treatment with promethazine in patients with severe COPD with and without asthma: death and severe exacerbations in a nationwide register study
por: Bonnesen, Barbara, et al.
Publicado: (2023)

COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
por: Higham, Andrew, et al.
Publicado: (2020)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Does inhaled corticosteroid use affect the risk of  COVID-19-related death?
por: Jordan, Alexander, et al.
Publicado: (2021)

Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

An obstructing endobronchial lipoma simulating COPD
por: Sivapalan, Pradeesh, et al.
Publicado: (2014)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
por: Kamstrup, Peter, et al.
Publicado: (2023)

Differential DNA methylation marks and gene comethylation of COPD in African-Americans with COPD exacerbations
por: Busch, Robert, et al.
Publicado: (2016)

Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study
por: Kamstrup, Peter, et al.
Publicado: (2023)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations
por: Lázár, Zsófia, et al.
Publicado: (2020)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD
por: Csoma, Balázs, et al.
Publicado: (2019)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
por: Bergsøe, Christina Marisa, et al.
Publicado: (2021)

Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol
por: Kefala, Anastasia M, et al.
Publicado: (2020)

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis
por: Jabarkhil, Ajmal, et al.
Publicado: (2020)

Models of infection and exacerbations in COPD
por: Papi, Alberto, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tpaijnnasjgmrba7m7m7uj3gii